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Letter
Palliative care in advanced 
coronavirus disease in 
intensive care units
Coronavirus disease (COVID-19) is 
rapidly developing throughout the 
world.1 Although many do not have 
severe symptoms, a minority (about 
5%) develop an advanced form 
and are admitted to intensive care 
units.2 There is no known cure, and 
a significant proportion die in these 
units. Iran is one of those countries 
struggling with the disease.3 Our 
experience shows that in addition 
to the therapeutic measures, pallia-
tive care is also required.
These patients suffer during the 
last days of their lives in intensive 
care units. Severe symptoms, body 
pain, dry cough, death anxiety, 
chills, fear of imminent death, 
gastrointestinal problems and 
shortness of breath affect patients 
physically and mentally. In some, 
the disease progresses rapidly, the 
patient cannot adapt. As there is no 
specific cure (and the patient is also 
aware of this) they becomes stressed 
and helpless. Our patients usually 
accepted death during the final 
stages but suffered from the difficult 
death that they knew awaited them. 
They preferred to die elsewhere 
and under different circumstances. 
In some, it was more difficult for 
them to endure the conditions of 
the intensive care units and their 
clinical status than death itself.
The family, as a support system, 
can play a vital role in such critical 
situations. In advanced COVID-19 
hospitalised in intensive care, family 
relationships are completely discon-
nected. In a very stressful situation, 
those with COVID-19 are deprived 
of this essential support system. 
Many longed to be with their family 
and even to see them for a moment 
before their death. In addition to 
the family disconnection, patients 
may not receive the necessary symp-
tomatic care in the intensive care 
units. Due to the critical conditions, 
the medical team may undervalue 
palliative care. Additionally, many 
hospitals may not have sufficient 
staff and resources to provide it.
Given that many patients are 
hospitalised in our intensive care 
units with COVID-19 (and many 
are dying) than others affected 
witness the disease development in 
fellow sufferers; they see other die 
and realise what lies ahead. This 
issue was usually very frightening. 
Some openly acknowledged death 
would come to them and their 
condition would become more 
difficult. Many requested more 
anaesthesia and sedation to mini-
mise the consequent distress.
Given the rapid spread of 
COVID-19 throughout the world 
and the large number with advanced 
disease, organisations developing 
health and care protocols to respond 
(including the WHO) must consider 
a comprehensive palliative care 
protocol for advanced COVID-19. 
The need for palliative care among 
these patients is paramount.
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